|
🐜
|
2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative.
35 auth.
D. Aletaha,
T. Neogi,
A. Silman,
Julia Funovits,
D. Felson,
C. Bingham,
Neal S Birnbaum,
G. Burmester,
V. Bykerk,
Marc D Cohen,
B. Combe,
K. Costenbader,
M. Dougados,
P. Emery,
G. Ferraccioli,
...
J. Hazes,
Kathryn Hobbs,
T. Huizinga,
A. Kavanaugh,
Jonathan Kay,
T. Kvien,
Timothy J. Laing,
P. Mease,
Henri A. Ménard,
Larry W. Moreland,
R. Naden,
Theodore Pincus,
J. Smolen,
E. Stanisławska-Biernat,
D. Symmons,
P. Tak,
K. Upchurch,
J. Vencovský,
F. Wolfe,
G. Hawker
|
11 |
2010 |
11
🐜
|
|
🐜
|
Guidelines for musculoskeletal ultrasound in rheumatology
8 auth.
M. Backhaus,
G. Burmester,
T. Gerber,
W. Grassi,
K. Machold,
W. A. Swen,
...
R. Wakefield,
B. Manger
|
10 |
2001 |
10
🐜
|
|
🐜
|
European League Against Rheumatism (EULAR) recommendations for the management of psoriatic arthritis with pharmacological therapies: 2015 update
34 auth.
L. Gossec,
J. Smolen,
S. Ramiro,
M. Wit,
M. Cutolo,
M. Dougados,
P. Emery,
R. Landewé,
Sue Oliver,
D. Aletaha,
N. Betteridge,
J. Braun,
G. Burmester,
J. Cañete,
N. Damjanov,
...
O. FitzGerald,
E. Haglund,
P. Helliwell,
T. Kvien,
R. Lories,
T. Luger,
M. Maccarone,
H. Marzo-Ortega,
D. McGonagle,
I. McInnes,
I. Olivieri,
K. Pavelka,
G. Schett,
J. Sieper,
F. Bosch,
D. Veale,
J. Wollenhaupt,
A. Zink,
D. Heijde
|
9 |
2015 |
9
🐜
|
|
🐜
|
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update
48 auth.
J. Smolen,
R. Landewé,
S. Bergstra,
A. Kerschbaumer,
A. Sepriano,
D. Aletaha,
R. Caporali,
C. Edwards,
K. Hyrich,
J. Pope,
Savia de Souza,
T. Stamm,
T. Takeuchi,
P. Verschueren,
K. Winthrop,
...
A. Balsa,
J. Bathon,
M. Buch,
G. Burmester,
F. Buttgereit,
M. Cardiel,
K. Chatzidionysiou,
C. Codreanu,
M. Cutolo,
A. D. den Broeder,
K. El Aoufy,
A. Finckh,
J. Fonseca,
J. Gottenberg,
E. Haavardsholm,
A. Iagnocco,
K. Lauper,
Zhanguo Li,
I. McInnes,
E. Mysler,
P. Nash,
G. Poór,
G. Ristić,
F. Rivellese,
A. Rubbert-Roth,
H. Schulze-Koops,
N. Stoilov,
Anja Strangfeld,
A. H. M. van der Helm-van Mil,
E. van Duuren,
T. V. Vliet Vlieland,
R. Westhovens,
D. M. van der Heijde
|
9 |
2022 |
9
🐜
|
|
🐜
|
Evaluation of a novel 7-joint ultrasound score in daily rheumatologic practice: a pilot project.
14 auth.
M. Backhaus,
S. Ohrndorf,
H. Kellner,
J. Strunk,
T. M. Backhaus,
W. Hartung,
H. Sattler,
Katinka Albrecht,
J. Kaufmann,
Karsten Becker,
...
H. Sörensen,
L. Meier,
G. Burmester,
W. Schmidt
|
8 |
2009 |
8
🐜
|
|
🐜
|
Efficacy and safety of certolizumab pegol plus methotrexate in active rheumatoid arthritis: the RAPID 2 study. A randomised controlled trial
13 auth.
J. Smolen,
R. Landewé,
P. Mease,
J. Brzezicki,
D. Mason,
K. Luijtens,
R. Vollenhoven,
A. Kavanaugh,
M. Schiff,
G. Burmester,
...
V. Strand,
J. Vencovský,
D. Heijde
|
8 |
2008 |
8
🐜
|
|
🐜
|
European League Against Rheumatism recommendations for the management of psoriatic arthritis with pharmacological therapies
35 auth.
L. Gossec,
J. Smolen,
C. Gaujoux-Viala,
Z. Ash,
H. Marzo-Ortega,
D. Heijde,
O. FitzGerald,
D. Aletaha,
P. Bálint,
D. Boumpas,
Jürgen Braun,
F. Breedveld,
G. Burmester,
J. Cañete,
M. Wit,
...
H. Dagfinrud,
K. Vlam,
M. Dougados,
P. Helliwell,
A. Kavanaugh,
T. Kvien,
R. Landewé,
T. Luger,
M. Maccarone,
D. McGonagle,
N. McHugh,
I. McInnes,
C. Ritchlin,
J. Sieper,
P. Tak,
G. Valesini,
J. Vencovský,
K. Winthrop,
A. Zink,
P. Emery
|
8 |
2011 |
8
🐜
|
|
🐜
|
Comparison of lumiracoxib with naproxen and ibuprofen in the Therapeutic Arthritis Research and Gastrointestinal Event Trial (TARGET), cardiovascular outcomes: randomised controlled trial
18 auth.
M. Farkouh,
H. Kirshner,
R. Harrington,
S. Ruland,
F. Verheugt,
T. Schnitzer,
G. Burmester,
E. Mysler,
M. Hochberg,
M. Doherty,
...
E. Ehrsam,
X. Gitton,
G. Krammer,
B. Mellein,
A. Gimona,
P. Matchaba,
C. Hawkey,
J. Chesebro
|
8 |
2004 |
8
🐜
|
|
🐜
|
Safety analyses of adalimumab (HUMIRA) in global clinical trials and US postmarketing surveillance of patients with rheumatoid arthritis
7 auth.
M. Schiff,
G. Burmester,
Jeffrey M Kent,
A. Pangan,
H. Kupper,
S. Fitzpatrick,
...
C. Donovan
|
8 |
2005 |
8
🐜
|
|
🐜
|
Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2010
20 auth.
D. Furst,
E. Keystone,
J. Braun,
F. Breedveld,
G. Burmester,
F. De Benedetti,
T. Dorner,
P. Emery,
R. Fleischmann,
A. Gibofsky,
...
J. Kalden,
A. Kavanaugh,
B. Kirkham,
P. Mease,
J. Sieper,
N. Singer,
J. Smolen,
P. Van Riel,
M. Weisman,
K. Winthrop
|
8 |
2011 |
8
🐜
|
|
🐜
|
Safety of extended treatment with anakinra in patients with rheumatoid arthritis
10 auth.
R. Fleischmann,
J. Tesser,
M. Schiff,
J. Schechtman,
G. Burmester,
R. Bennett,
...
D. Modafferi,
Lifen Zhou,
Debbie Bell,
B. Appleton
|
8 |
2006 |
8
🐜
|
|
🐜
|
EULAR report on the use of ultrasonography in painful knee osteoarthritis. Part 1: Prevalence of inflammation in osteoarthritis
16 auth.
M. D’Agostino,
P. Conaghan,
M. Bars,
G. Baron,
W. Grassi,
E. Martı́n-Mola,
R. Wakefield,
J. Brasseur,
A. So,
M. Backhaus,
...
M. Malaise,
G. Burmester,
N. Schmidely,
P. Ravaud,
M. Dougados,
P. Emery
|
8 |
2005 |
8
🐜
|
|
🐜
|
Rituximab inhibits structural joint damage in patients with rheumatoid arthritis with an inadequate response to tumour necrosis factor inhibitor therapies
14 auth.
E. Keystone,
P. Emery,
C. Peterfy,
P. Tak,
Stanley N. Cohen,
M. Genovese,
M. Dougados,
G. Burmester,
M. Greenwald,
T. Kvien,
...
Sarah Williams,
D. Hagerty,
M. Cravets,
T. Shaw
|
8 |
2008 |
8
🐜
|
